|   | |
| Clinical data | |
|---|---|
| Other names | RS-2362; Fluocinolone acetonide propionate; Fluocinolone acetonide 21-propionate; 6α,9α-Difluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-propionate; 6α,9α-Difluoro-11β-hydroxy-16α,17α-[isopropylidenebis(oxy)]pregna-1,4-diene-3,20-dione 21-propionate | 
| Drug class | Corticosteroid; Glucocorticoid | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.055.699 | 
| Chemical and physical data | |
| Formula | C27H34F2O7 | 
| Molar mass | 508.559 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Procinonide (developmental code RS-2362; also known as fluocinolone acetonide propionate) is a synthetic glucocorticoid corticosteroid which was never marketed. [1]